Detalhe da pesquisa
1.
Comparing psychotic experiences in low-and-middle-income-countries and high-income-countries with a focus on measurement invariance.
Psychol Med
; 52(8): 1509-1516, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33023691
2.
Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Psychol Med
; 51(4): 538-549, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653423
3.
Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Brain Behav Immun
; 88: 547-558, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32330592
4.
The characteristics of psychotic features in bipolar disorder.
Psychol Med
; 49(12): 2036-2048, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30303059
5.
Psychological Symptoms in Primary Immunodeficiencies: a Common Comorbidity?
J Clin Immunol
; 42(3): 695-698, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35043302
6.
Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients.
Brain Behav Immun
; 52: 178-186, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26541453
7.
Towards a blood-based diagnostic panel for bipolar disorder.
Brain Behav Immun
; 52: 49-57, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26441135
8.
Reply to interleukin-6 in schizophrenia: Cause of death matters.
Brain Behav Immun
; 90: 383-384, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32889080
9.
Cross-sectional association between metabolic parameters and psychotic-like experiences in a population-based sample of middle-aged and elderly individuals.
Schizophr Res
; 261: 145-151, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37757577
10.
An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces.
Int J Neuropsychopharmacol
; 14(6): 746-55, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21255481
11.
TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
Brain Behav Immun
; 25(6): 1162-9, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21421043
12.
Activated PI3Kδ syndrome, an immunodeficiency disorder, leads to sensorimotor deficits recapitulated in a murine model.
Brain Behav Immun Health
; 18: 100377, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34786564
13.
The search for an autoimmune origin of psychotic disorders: Prevalence of autoantibodies against hippocampus antigens, glutamic acid decarboxylase and nuclear antigens.
Schizophr Res
; 228: 462-471, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33581586
14.
The effect of antipsychotic medication on facial affect recognition in schizophrenia: a review.
Psychiatry Res
; 178(1): 1-9, 2010 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20452051
15.
Diurnal cortisol patterns of young male patients with schizophrenia.
Psychiatry Clin Neurosci
; 64(5): 548-54, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20923433
16.
Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design.
Trials
; 21(1): 492, 2020 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513294
17.
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
Trials
; 21(1): 147, 2020 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32033579
18.
Multimodel inference for biomarker development: an application to schizophrenia.
Transl Psychiatry
; 9(1): 83, 2019 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745560
19.
Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis.
Eur Neuropsychopharmacol
; 29(7): 835-846, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31230885
20.
Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo.
Sci Adv
; 5(5): eaau9093, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31086815